scholarly article | Q13442814 |
P2093 | author name string | A. R. HIGGINS | |
M. A. KADER | |||
T. M. FLOYD | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Shigella | Q131029 |
infection | Q166231 | ||
Vaccines and vaccination | Q34391712 | ||
P1104 | number of pages | 8 | |
P304 | page(s) | 281-288 | |
P577 | publication date | 1955-03-01 | |
P1433 | published in | American Journal of Tropical Medicine and Hygiene | Q15766943 |
P1476 | title | Studies in shigellosis. III. A controlled evaluation of a monovalent Shigella vaccine in a highly endemic environment | |
P478 | volume | 4 |
Q36431701 | Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain |
Q39573053 | Construction of a stable attenuated Shigella sonnei DeltavirG vaccine strain, WRSS1, and protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model |
Q42822103 | Coproantibody and bacterial antagonism as protective factors in experimental enteric cholera |
Q36912891 | Diarrhoeal disease and its control |
Q42822127 | Experimental enteric Shigella and Vibrio infections in mice and guinea pigs |
Q40267400 | Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models. |
Q35772614 | Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines. |
Q40210819 | Molecular analysis of variant plasmid forms of a bivalent Salmonella typhi-Shigella sonnei vaccine strain |
Q33628356 | New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development |
Q40168452 | Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen |
Q40211202 | Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis |
Q35424942 | Protection against local Shigella sonnei infection in mice by parenteral immunization with a nucleoprotein subcellular vaccine |
Q36900226 | Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies |
Q35163992 | Protection of Monkeys Against Experimental Shigellosis with Attenuated Vaccines. |
Q93924968 | Questions and Comments |
Q35443019 | Recognition of three epitopic regions on invasion plasmid antigen C by immune sera of rhesus monkeys infected with Shigella flexneri 2a. |
Q40614472 | Role of antigen form in development of mucosal immunoglobin A response to Shigella flexneri Antigens |
Q34008338 | Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults |
Q34006223 | Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel |
Q36989057 | Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains |
Search more.